(5Z)-5-({2-[(2-chloro-1,3-thiazol-5-yl)methoxy]phenyl}methylidene)-2-sulfanylidene-1,3-thiazolidin-4-one

Catalog No. :
ACDIYU753
CAS No. :
860784-28-7
Molecular Formula :
C14H9ClN2O2S3
Molecular Weight :
368.89

IUPAC Name:(Z)-5-(2-((2-chlorothiazol-5-yl)methoxy)benzylidene)-2-thioxothiazolidin-4-one

(5Z)-5-({2-[(2-chloro-1,3-thiazol-5-yl)methoxy]phenyl}methylidene)-2-sulfanylidene-1,3-thiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5Z)-5-({2-[(2-chloro-1,3-thiazol-5-yl)methoxy]phenyl}methylidene)-2-sulfanylidene-1,3-thiazolidin-4-one
IUPAC Name(Z)-5-(2-((2-chlorothiazol-5-yl)methoxy)benzylidene)-2-thioxothiazolidin-4-one
MDL No.MFCD05975018
Molecular FormulaC14H9ClN2O2S3
Molecular Weight368.89
SMILESO=C1NC(S/C1=C\C2=CC=CC=C2OCC3=CN=C(Cl)S3)=S
InChI KeyHWDOAWGTMMXWPW-WZUFQYTHSA-N
Synonym5-((Z)-(2-[(2-CHLORO-1,3-THIAZOL-5-YL)METHOXY]PHENYL)METHYLIDENE)-2-THIOXO-1,3-THIAZOLAN-4-ONE;(5Z)-5-({2-[(2-chloro-1,3-thiazol-5-yl)methoxy]phenyl}methylidene)-2-sulfanylidene-1,3-thiazolidin-4-one;4-Thiazolidinone, 5-[[2-[(2-chloro-5-thiazolyl)methoxy]phenyl]methylene]-2-thioxo-
CAS No.860784-28-7

Synthetic Route by SureRoute

1. ACDIYU753 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDIYU753 route product structure diagram
    ACDIYU753860784-28-7
Inquiry

2. ACDIYU753 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTMRD043 route compound structure diagram
    ACTMRD043145015-15-2 In Stock
  4. Then
  5. ACDIYU753 route product structure diagram
    ACDIYU753860784-28-7
Inquiry

Comments (0)